Circadian rhythm of serum cortisol after repeated inhalation of the new topical steroid ciclesonide

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 2160-2163

  Weinbrenner, Anita ^a,b,c   Hüneke, Dagny ^a,b,c   Zschiesche, Michael ^a,b,c   Engel, Georg ^a,b,c   Timmer, Wolfgang ^a,b,c   Steinijans, Volker W ^a,b,c   Bethke, Thomas ^a,b,c   Wurst, Wilhelm ^a,b,c   Drollmann, Anton ^a,b,c   Kaatz, Hans Joachim ^a,b,c   Siegmund, Werner ^a,b,c  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b ALTANA PHARMA AG   (Germany)

^c Oranienburger Pharmawerk   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CICLESONIDE; GLUCOCORTICOID; HYDROCORTISONE; PLACEBO; UNCLASSIFIED DRUG;

ADRENAL SUPPRESSION; ADULT; ARTICLE; ASTHMA; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 18344393060     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.8447     Document Type: Article

References (28)

1. NIH conference. Airway inflammation
2. Airway wall remodeling in asthma
3. Molecular genetics of chronic obstructive pulmonary disease
4. Glukokortikoide
5. New perspectives on inhaled drug delivery and systemic bioactivity
6. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5′-monophosphate in asthmatic patients
7. ICH Harmonised Tripartite Guideline for Good Clinical Practice (ICH Topic E6) as approved by Committee for Proprietary Medicinal Products at July 17th 1996, and effective since January 17th, 1997; issued as CPMP/ICH/135/95, Step 5
8. Presentation of results from bioequivalence studies
9. Nocturnal cortisol secretion in healthy adults before and after inhalation of budesonide
10. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler
11. Assessment of the systemic effects of inhaled glucocorticoids: The infuence of blood sampling techniques and frequency on plasma cortisol and leucocytes
12. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers
13. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients
14. Measuring the systemic effects of inhaled beclomethasone: Timed morning urine collections compared with 24 hour specimens
15. Adrenocortical function after chronic inhalation of fluocortinbutyl and beclomethasone dipropionate
16. Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids
17. Adrenal function of children with bronchial asthma treated with beclomethasone dipropionate
18. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects
19. Assessment of the relative systemic potency of inhaled fluticasone and budesonide
20. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers
21. Dose-response of inhaled drugs in asthma. An update
22. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects
23. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers
24. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor
25. The human pharmacology of fluticasone propionate
26. Diurnal variation in suppression of adrenal function by glucocorticoids
27. Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity